Biotech entity
All 1 tracked stories fall under one category: fda-approval. All India Institute of Medical Sciences (AIIMS) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. AIIMS-CAPFIMS appears in 1 tracked Biotech story from July 6, 2026.
Last mentioned: Jul 6, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: fda-approval. All India Institute of Medical Sciences (AIIMS) is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. AIIMS-CAPFIMS appears in 1 tracked Biotech story from July 6, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 2 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering AIIMS-CAPFIMS. Shared-story counts are live from our verified record — not editorial picks.
By filling 460+ faculty posts, AIIMS significantly expands its research capacity, positioning itself for breakthroughs in biomedical science. The influx of professors and early-career researchers will drive clinical trials, publications, and innovation, supported by a transparent blockchain-based selection process.
AIIMS-CAPFIMS is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
